Biotech · Private company
SynDevRx, Inc.
Track this companyFree. Adds SynDevRx, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials32 recruiting or active
Pipeline programs2From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline2
- EvexomostatPhase 2 · HR+/HER2-negative Breast CancerClinicalTrials.gov · fetched Nov 12, 2026
- SDX-7320Phase 1 · Advanced MalignancyClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- A Study of SDX-7320 in Combination With Eribulin for People With Breast CancerPHASE2 · RECRUITING · started Oct 3, 2022ClinicalTrials.gov NCT05570253 · fetched Nov 12, 2026
- Evexomostat Plus PI3K or AKT Inhibitor and Fulvestrant in Patients With a PI3K Alteration and HR+/Her2- Breast CancerPHASE1_PHASE2 · RECRUITING · started Aug 26, 2022ClinicalTrials.gov NCT05455619 · fetched Nov 12, 2026
- A Dose Escalation Study of SDX-7320 in Patients With Advanced Refractory or Late-Stage Solid TumorsPHASE1 · COMPLETED · started Feb 1, 2016ClinicalTrials.gov NCT02743637 · fetched Nov 12, 2026